#1 Clinical Trials Search in Europe

Trandolapril

This article summarizes several clinical trials investigating the use of Trandolapril, an angiotensin-converting enzyme (ACE) inhibitor, in treating hypertension and other medical conditions. These studies examine Trandolapril’s effectiveness, safety profile, and potential benefits compared to other treatments. The trials cover various aspects, including bioequivalence studies, combination therapies, and its effects on specific patient populations such as those with diabetes or aortic stenosis.

Table of Contents

What is Trandolapril?

Trandolapril is a medication that belongs to a class of drugs called Angiotensin-Converting Enzyme (ACE) inhibitors. It is known by various brand names, including Mavik and Gopten[1]. Trandolapril is also available in combination with other medications, such as verapamil, under brand names like Tarka, VeraTran, or ABT-TARKA[1][2].

Uses of Trandolapril

Trandolapril is primarily used to treat the following conditions:

  • Hypertension (High Blood Pressure): Trandolapril is effective in lowering blood pressure in patients with hypertension[3].
  • Coronary Artery Disease (CAD): It is used in the management of patients with CAD, often in combination with other medications[4].
  • Diabetic Nephropathy: Trandolapril may help prevent or slow the progression of kidney disease in patients with type 2 diabetes[1].

How Trandolapril Works

Trandolapril works by inhibiting the angiotensin-converting enzyme (ACE) in the body. This enzyme is responsible for producing a substance called angiotensin II, which causes blood vessels to narrow. By blocking this enzyme, trandolapril helps blood vessels relax and widen, which lowers blood pressure and improves blood flow[5].

Forms and Dosages

Trandolapril is available in tablet form and comes in various strengths, including:

  • 0.5 mg
  • 1 mg
  • 2 mg
  • 4 mg

The dosage may vary depending on the patient’s condition and response to treatment. In some studies, dosages were escalated from 0.5 mg to 4 mg daily over several weeks[3].

Clinical Studies

Several clinical studies have been conducted to evaluate the efficacy and safety of trandolapril:

  • TRAIL Study: This study examined the effects of escalating doses of trandolapril on lowering blood pressure in patients with Stage 1-2 hypertension[3].
  • BENEDICT Study: This study investigated the use of trandolapril, alone or in combination with verapamil, in preventing kidney disease in patients with type 2 diabetes[1].
  • INVEST Study: This large international study compared treatment strategies involving trandolapril and other medications in patients with hypertension and coronary artery disease[4].
  • MEAD Study: This study looked at the metabolic effects of trandolapril in people with metabolic syndrome, a condition that increases the risk of diabetes and heart disease[5].

Side Effects and Safety

While trandolapril is generally well-tolerated, it can cause side effects in some patients. Common side effects may include:

  • Dizziness
  • Headache
  • Cough
  • Fatigue

In clinical trials, the safety of trandolapril was closely monitored. For example, in the MEAD study, researchers specifically looked at how trandolapril affected blood sugar levels in people at risk for diabetes[5].

Special Considerations

There are some special considerations to keep in mind when using trandolapril:

  • Pregnancy: Trandolapril can harm an unborn baby and should not be used during pregnancy.
  • Kidney Function: Patients with kidney problems may need dose adjustments.
  • Aortic Stenosis: While traditionally contraindicated, some studies have investigated the use of ACE inhibitors like trandolapril in patients with aortic stenosis (narrowing of the aortic valve)[6].
  • Combination Therapy: Trandolapril is often used in combination with other medications, such as verapamil or hydrochlorothiazide, for better blood pressure control[2][4].

Always consult with your healthcare provider before starting or changing any medication regimen. They can provide personalized advice based on your specific health conditions and needs.

Aspect Details
Primary Use Treatment of hypertension (high blood pressure)
Drug Class Angiotensin-converting enzyme (ACE) inhibitor
Combination Therapies Studied with Verapamil (calcium channel blocker) and hydrochlorothiazide (diuretic)
Patient Populations Hypertensive patients, diabetics, those with coronary artery disease, and aortic stenosis
Study Types Bioequivalence studies, efficacy trials, safety assessments
Key Outcomes Measured Blood pressure control, cardiovascular events, kidney function, glucose tolerance
Study Durations Ranging from short-term bioequivalence studies to multi-year trials
Notable Findings Potential benefits in preventing diabetic nephropathy, efficacy in blood pressure control

FAQ

  • What is Trandolapril used for? Trandolapril is primarily used to treat hypertension (high blood pressure). Some studies also investigate its potential benefits for patients with diabetes, coronary artery disease, and aortic stenosis.
  • How does Trandolapril work? Trandolapril is an angiotensin-converting enzyme (ACE) inhibitor. It works by relaxing blood vessels, which helps lower blood pressure and improves blood flow.
  • Are there any combination therapies involving Trandolapril? Yes, some studies examine the effectiveness of Trandolapril in combination with other medications. For example, one trial investigates the combination of Trandolapril with Verapamil, a calcium channel blocker, for treating hypertension.
  • What are some of the side effects studied in these trials? While specific side effects aren't detailed in the provided information, the trials generally monitor for adverse events and ensure patient safety. Some studies also look at the drug's effects on blood sugar levels and the risk of developing diabetes.
  • How long do these clinical trials typically last? The duration of the trials varies. Some bioequivalence studies are short-term, while others, like the BENEDICT study for diabetic nephropathy prevention, can last for several years to observe long-term effects.

Ongoing Clinical Trials on Trandolapril

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    3 1 1 1
    Investigated drugs:
    Italy

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +5

Glossary

  • Trandolapril: An angiotensin-converting enzyme (ACE) inhibitor medication used primarily to treat high blood pressure.
  • Hypertension: A medical condition characterized by persistently elevated blood pressure in the arteries, often defined as blood pressure of 140/90 mm Hg or higher.
  • Bioequivalence: The property of two drug products having identical active ingredients and producing the same biological effects when administered under similar conditions.
  • ACE inhibitor: A class of medications that work by inhibiting the angiotensin-converting enzyme, which helps to relax blood vessels and lower blood pressure.
  • Calcium channel blocker: A type of medication that blocks calcium channels in the heart and blood vessel walls, helping to relax and widen blood vessels.
  • Metabolic syndrome: A cluster of conditions including high blood pressure, high blood sugar, abnormal cholesterol levels, and excess body fat around the waist, which together increase the risk of heart disease, stroke, and diabetes.
  • Aortic stenosis: A narrowing of the aortic valve opening, which restricts blood flow from the left ventricle to the aorta and may also affect the pressure in the left atrium.
  • Nephropathy: Kidney disease or damage, often associated with diabetes or high blood pressure.
  • Microalbuminuria: The presence of small amounts of albumin (a protein) in the urine, often an early sign of kidney damage.
  • Glucose tolerance: The body's ability to process and regulate blood sugar levels after consuming glucose.

References

  1. https://clinicaltrials.gov/study/NCT00235014
  2. https://clinicaltrials.gov/study/NCT00235001
  3. https://clinicaltrials.gov/study/NCT00233532
  4. https://clinicaltrials.gov/study/NCT00133692
  5. https://clinicaltrials.gov/study/NCT00887510
  6. https://clinicaltrials.gov/study/NCT00252317